<DOC>
	<DOCNO>NCT00960830</DOCNO>
	<brief_summary>The purpose study evaluate use antidepressant medication depress patient implantable cardioverter defibrillator reduce number ICD 's shock improve depressive affect .</brief_summary>
	<brief_title>Mirtazapine Reduces ICD Shocks ICD Patients With Depression Anxiety</brief_title>
	<detailed_description>episode arrhythmia remain present even icd implantation , specially true depressed patient . hypothesize improve mood state mean antidepressant drug . namely mirtazapine . could responsible alleviate number appropriate shock deliver cardioverter . could due direct effect drug indirect effect improve anxious depressive affect . mood anxiety state measure HADS scale</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Mirtazapine</mesh_term>
	<mesh_term>Mianserin</mesh_term>
	<criteria>cardioverter implant patient depression anxiety heart failure diseases reduce physical fitness</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>87 Years</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>